How to buy Clinigen Group (CLIN) shares

Learn how to easily invest in Clinigen Group shares.

Clinigen Group plc (CLIN) is a publicly traded medical distribution business based in the UK. It opened the day at 644p after a previous close of 629p. During the day the price has varied from a low of 611p to a high of 644p. The latest price was 628.5p (25 minute delay). Clinigen Group is listed on the London Stock Exchange (LSE) and employs 1,000 staff. All prices are listed in pence sterling.

How to buy shares in Clinigen Group

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CLIN in this case.
  5. Research Clinigen Group shares. The platform should provide the latest information available.
  6. Buy your Clinigen Group shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x Clinigen Group shares with popular platforms

Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £0.00
£628.50 total
Capital at risk
IG Share Dealing logo £0 £250 £8.00
£636.50 total
Capital at risk
Fineco logo £0 No minimum £0.00
£628.50 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £11.95
£640.45 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.84
£630.34 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £7.99
£636.49 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £9.50
£638.00 total
Capital at risk

Full comparison of share dealing platforms

Clinigen Group share price (LSE:CLIN)

Use our graph to track the performance of CLIN stocks over time.

Clinigen Group price performance over time

Historical closes compared with the last close of 628.5p

6 months (2022-04-04) -32.05%
1 year (2021-10-05) -0.71%
2 years (2020-10-05) -11.48%
3 years (2019-10-04) -26.71%
5 years (2017-10-05) -45.87%

Is it a good time to buy Clinigen Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
IG bxs hero

Invest in Clinigen Group shares with IG

  • No commission on US shares
  • More than 13,000 shares to invest in
  • Open your account in minutes

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Clinigen Group under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Clinigen Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, Clinigen Group shares trade at around 65x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

EBITDA

Clinigen Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £105.6 million.

The EBITDA is a measure of a Clinigen Group's overall financial performance and is widely used to measure a its profitability.

Clinigen Group shares at a glance

Information last updated 2021-06-16.
Open644p
High644p
Low611p
Close628.5p
Previous close629p
Change-0.5p
Change %-0.0795%
Volume603,159
Information last updated 2022-05-03.
52-week range541.4531p - 948.0488p
50-day moving average899.445p
200-day moving average745.2612p
Wall St. target price821.8p
PE ratio64.6853
Dividend yield5.5p (0.82%)
Earnings per share (TTM)14.3p

Clinigen Group share dividends

0.8%

Dividend yield: 0.82% of stock value

0.8%

Forward annual dividend yield: 0.82% of stock value

36.8%

Dividend payout ratio: 36.76% of net profits

Clinigen Group has recently paid out dividends equivalent to 0.82% of its share value annually.

Clinigen Group has paid out, on average, around 36.76% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 0.82% return on their shares, in the form of dividend payments. In Clinigen Group's case, that would currently equate to about 5.5p per share.

While Clinigen Group's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.

The latest dividend was paid out to all shareholders who bought their shares by 2 December 2021 (the "ex-dividend date").

Share price volatility

Over the last 12 months, Clinigen Group's shares have ranged in value from as little as 541.4531p up to 948.0488p. A popular way to gauge a stock's volatility is its "beta".

CLIN.LSE volatility(beta: 1.44)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Clinigen Group's is 1.4399. This would suggest that Clinigen Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site